A 3D‐Engineered Conformal Implant Releases DNA Nanocomplexs for Eradicating the Postsurgery Residual Glioblastoma

Gene therapy has great promise for glioblastoma treatment; however, it remains a great challenge to efficiently deliver genes to the brain. The incomplete resection of glioblastoma always leads to poor prognosis. Here, a 3D‐engineered conformal implant for eradicating the postsurgery residual glioblastoma is designed. This implant is constructed by 3D‐printing technology to match the tumor cavity and release an oncolytic virus‐inspired DNA nanocomplex to kill glioblastoma cells through apoptosis induction. Meanwhile, a 3D‐engineered subcutaneous glioblastoma xenograft is built to mimic the resection tumor cavity in mice. Insertion of the implant into the glioblastoma resection cavity efficiently delays tumor recurrence and significantly prolongs overall survival. This study provides a proof‐of‐concept of glioblastoma therapy using a conformal implant that releases oncolytic DNA nanocomplexs. This strategy can lead to the development of future precision therapy for eradicating postsurgery residual tumors.

[1]  Kanwal Rehman,et al.  Recent progress in biomedical applications of Pluronic (PF127): Pharmaceutical perspectives. , 2015, Journal of controlled release : official journal of the Controlled Release Society.

[2]  K. Kohn.  Interstrand cross-linking of DNA by 1,3-bis(2-chloroethyl)-1-nitrosourea and other 1-(2-haloethyl)-1-nitrosoureas. , 1977, Cancer research.

[3]  R. Xu,et al.  Tumourigenicity and Immunogenicity of Induced Neural Stem Cell Grafts Versus Induced Pluripotent Stem Cell Grafts in Syngeneic Mouse Brain , 2016, Scientific Reports.

[4]  Manfred Westphal,et al.  Circulating biomarkers for gliomas , 2015, Nature Reviews Neurology.

[5]  Yuquan Wei,et al.  Efficient inhibition of intraperitoneal human ovarian cancer growth and prolonged survival by gene transfer of vesicular stomatitis virus matrix protein in nude mice. , 2007, Gynecologic oncology.

[6]  A. Khademhosseini,et al.  Synthesis, properties, and biomedical applications of gelatin methacryloyl (GelMA) hydrogels. , 2015, Biomaterials.

[7]  Liu Yanhui,et al.  Survival analysis for valproic acid use in adult glioblastoma multiforme: A meta-analysis of individual patient data and a systematic review , 2014, Seizure.

[8]  Yuquan Wei,et al.  Efficient Inhibition of Ovarian Cancer by Gelonin Toxin Gene Delivered by Biodegradable Cationic Heparin-polyethyleneimine Nanogels , 2015, International journal of medical sciences.

[9]  G. Reifenberger,et al.  EANO guideline for the diagnosis and treatment of anaplastic gliomas and glioblastoma. , 2014, The Lancet. Oncology.

[10]  R. Stupp,et al.  Phase II Study of Radiotherapy and Temsirolimus versus Radiochemotherapy with Temozolomide in Patients with Newly Diagnosed Glioblastoma without MGMT Promoter Hypermethylation (EORTC 26082) , 2016, Clinical Cancer Research.

[11]  Luigi Naldini,et al.  Gene therapy returns to centre stage , 2015, Nature.

[12]  Yi Su,et al.  The relationship between cerebrospinal fluid markers of Alzheimer pathology and positron emission tomography tau imaging. , 2016, Brain : a journal of neurology.

[13]  Yunfeng Lu,et al.  Efficient Delivery of Therapeutic miRNA Nanocapsules for Tumor Suppression , 2015, Advanced materials.

[14]  R. Tamargo,et al.  The intracerebral distribution of BCNU delivered by surgically implanted biodegradable polymers. , 1992, Journal of neurosurgery.

[15]  D. Gutmann,et al.  Advances in the treatment of neurofibromatosis-associated tumours , 2013, Nature Reviews Clinical Oncology.

[16]  Salvatore Piscuoglio,et al.  Cerebrospinal fluid-derived circulating tumour DNA better represents the genomic alterations of brain tumours than plasma , 2015, Nature Communications.

[17]  Yu Zhou,et al.  Vesicular stomatitis virus matrix protein (VSVMP) inhibits the cell growth and tumor angiogenesis in oral squamous cell carcinoma. , 2012, Oral oncology.

[18]  Jos Malda,et al.  Gelatin-Methacryloyl Hydrogels: Towards Biofabrication-Based Tissue Repair. , 2016, Trends in biotechnology.

[19]  Yong Peng,et al.  The role of MicroRNAs in human cancer , 2016, Signal Transduction and Targeted Therapy.

[20]  Xiongbin Lu,et al.  Hyaluronic acid-decorated dual responsive nanoparticles of Pluronic F127, PLGA, and chitosan for targeted co-delivery of doxorubicin and irinotecan to eliminate cancer stem-like cells. , 2015, Biomaterials.

[21]  Yuquan Wei,et al.  Efficient inhibition of C-26 colon carcinoma by VSVMP gene delivered by biodegradable cationic nanogel derived from polyethyleneimine. , 2010, ACS nano.

[22]  F. Wen,et al.  Matrix protein of vesicular stomatitis virus: a potent inhibitor of vascular endothelial growth factor and malignant ascites formation , 2013, Cancer Gene Therapy.

[23]  Thomas C. Chen,et al.  Maintenance Therapy With Tumor-Treating Fields Plus Temozolomide vs Temozolomide Alone for Glioblastoma: A Randomized Clinical Trial. , 2015, JAMA.

[24]  A. Cenic,et al.  Biopsy versus partial versus gross total resection in older patients with high-grade glioma: a systematic review and meta-analysis. , 2015, Neuro-oncology.

[25]  Zhi-Min Yuan,et al.  CRISPR‐Cas9 systems: versatile cancer modelling platforms and promising therapeutic strategies , 2016, International journal of cancer.

[26]  R. Roesler,et al.  Anti-proliferative effect of the gastrin-release peptide receptor antagonist RC-3095 plus temozolomide in experimental glioblastoma models , 2009, Journal of Neuro-Oncology.

[27]  John S. Winestone,et al.  Delivery of temozolomide to the tumor bed via biodegradable gel matrices in a novel model of intracranial glioma with resection , 2009, Journal of Neuro-Oncology.

[28]  J. Royds,et al.  Alternative lengthening of telomeres and survival in patients with glioblastoma multiforme , 2003, The Lancet.

[29]  K. Shah,et al.  Encapsulated therapeutic stem cells implanted in the tumor resection cavity induce cell death in gliomas , 2011, Nature Neuroscience.